Clinical Trial Update: Allogeneic γδT Cells in Glioblastoma [NA]

View source ↗

Summary

A clinical trial evaluating allogeneic γδT cells in glioblastoma is currently recruiting, sponsored by Peking University Third Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Allogeneic γδT Cells

Snippet

Sponsor: Peking University Third Hospital | Conditions: Glioblastoma (GBM), Glioblastoma Multiforme (GBM) | NA | Status: RECRUITING